367 related articles for article (PubMed ID: 29695788)
1. TFAP2C regulates transcription in human naive pluripotency by opening enhancers.
Pastor WA; Liu W; Chen D; Ho J; Kim R; Hunt TJ; Lukianchikov A; Liu X; Polo JM; Jacobsen SE; Clark AT
Nat Cell Biol; 2018 May; 20(5):553-564. PubMed ID: 29695788
[TBL] [Abstract][Full Text] [Related]
2. The TFAP2C-Regulated OCT4 Naive Enhancer Is Involved in Human Germline Formation.
Chen D; Liu W; Zimmerman J; Pastor WA; Kim R; Hosohama L; Ho J; Aslanyan M; Gell JJ; Jacobsen SE; Clark AT
Cell Rep; 2018 Dec; 25(13):3591-3602.e5. PubMed ID: 30590035
[TBL] [Abstract][Full Text] [Related]
3. Analyzing bovine OCT4 and NANOG enhancer activity in pluripotent stem cells using fluorescent protein reporters.
Huang D; Wang L; Talbot NC; Huang C; Pu L; Zhao X; Tian X; Zhang M; Tang Y
PLoS One; 2018; 13(10):e0203923. PubMed ID: 30289916
[TBL] [Abstract][Full Text] [Related]
4. Sirtuin 1 Promotes Deacetylation of Oct4 and Maintenance of Naive Pluripotency.
Williams EO; Taylor AK; Bell EL; Lim R; Kim DM; Guarente L
Cell Rep; 2016 Oct; 17(3):809-820. PubMed ID: 27732856
[TBL] [Abstract][Full Text] [Related]
5. NANOG alone induces germ cells in primed epiblast in vitro by activation of enhancers.
Murakami K; Günesdogan U; Zylicz JJ; Tang WWC; Sengupta R; Kobayashi T; Kim S; Butler R; Dietmann S; Surani MA
Nature; 2016 Jan; 529(7586):403-407. PubMed ID: 26751055
[TBL] [Abstract][Full Text] [Related]
6. Multifaceted SOX2-chromatin interaction underpins pluripotency progression in early embryos.
Li L; Lai F; Hu X; Liu B; Lu X; Lin Z; Liu L; Xiang Y; Frum T; Halbisen MA; Chen F; Fan Q; Ralston A; Xie W
Science; 2023 Dec; 382(6676):eadi5516. PubMed ID: 38096290
[TBL] [Abstract][Full Text] [Related]
7. Ash2l interacts with Oct4-stemness circuitry to promote super-enhancer-driven pluripotency network.
Tsai PH; Chien Y; Wang ML; Hsu CH; Laurent B; Chou SJ; Chang WC; Chien CS; Li HY; Lee HC; Huo TI; Hung JH; Chen CH; Chiou SH
Nucleic Acids Res; 2019 Nov; 47(19):10115-10133. PubMed ID: 31555818
[TBL] [Abstract][Full Text] [Related]
8. RNA Targets Ribogenesis Factor WDR43 to Chromatin for Transcription and Pluripotency Control.
Bi X; Xu Y; Li T; Li X; Li W; Shao W; Wang K; Zhan G; Wu Z; Liu W; Lu JY; Wang L; Zhao J; Wu J; Na J; Li G; Li P; Shen X
Mol Cell; 2019 Jul; 75(1):102-116.e9. PubMed ID: 31128943
[TBL] [Abstract][Full Text] [Related]
9. A dynamic interplay of enhancer elements regulates
Xie L; Torigoe SE; Xiao J; Mai DH; Li L; Davis FP; Dong P; Marie-Nelly H; Grimm J; Lavis L; Darzacq X; Cattoglio C; Liu Z; Tjian R
Genes Dev; 2017 Sep; 31(17):1795-1808. PubMed ID: 28982762
[TBL] [Abstract][Full Text] [Related]
10. Distinct Enhancer Activity of Oct4 in Naive and Primed Mouse Pluripotency.
Choi HW; Joo JY; Hong YJ; Kim JS; Song H; Lee JW; Wu G; Schöler HR; Do JT
Stem Cell Reports; 2016 Nov; 7(5):911-926. PubMed ID: 28157483
[TBL] [Abstract][Full Text] [Related]
11. Oct4 differentially regulates chromatin opening and enhancer transcription in pluripotent stem cells.
Xiong L; Tolen EA; Choi J; Velychko S; Caizzi L; Velychko T; Adachi K; MacCarthy CM; Lidschreiber M; Cramer P; Schöler HR
Elife; 2022 May; 11():. PubMed ID: 35621159
[TBL] [Abstract][Full Text] [Related]
12. ZIC3 Controls the Transition from Naive to Primed Pluripotency.
Yang SH; Andrabi M; Biss R; Murtuza Baker S; Iqbal M; Sharrocks AD
Cell Rep; 2019 Jun; 27(11):3215-3227.e6. PubMed ID: 31189106
[TBL] [Abstract][Full Text] [Related]
13. YY1 and CTCF orchestrate a 3D chromatin looping switch during early neural lineage commitment.
Beagan JA; Duong MT; Titus KR; Zhou L; Cao Z; Ma J; Lachanski CV; Gillis DR; Phillips-Cremins JE
Genome Res; 2017 Jul; 27(7):1139-1152. PubMed ID: 28536180
[TBL] [Abstract][Full Text] [Related]
14. Coordination of germ layer lineage choice by TET1 during primed pluripotency.
Luo X; van der Veer BK; Sun L; Bartoccetti M; Boretto M; Vankelecom H; Khoueiry R; Koh KP
Genes Dev; 2020 Apr; 34(7-8):598-618. PubMed ID: 32115407
[TBL] [Abstract][Full Text] [Related]
15. OCT4 cooperates with distinct ATP-dependent chromatin remodelers in naïve and primed pluripotent states in human.
Huang X; Park KM; Gontarz P; Zhang B; Pan J; McKenzie Z; Fischer LA; Dong C; Dietmann S; Xing X; Shliaha PV; Yang J; Li D; Ding J; Lungjangwa T; Mitalipova M; Khan SA; Imsoonthornruksa S; Jensen N; Wang T; Kadoch C; Jaenisch R; Wang J; Theunissen TW
Nat Commun; 2021 Aug; 12(1):5123. PubMed ID: 34446700
[TBL] [Abstract][Full Text] [Related]
16. Enhancer Chromatin and 3D Genome Architecture Changes from Naive to Primed Human Embryonic Stem Cell States.
Battle SL; Doni Jayavelu N; Azad RN; Hesson J; Ahmed FN; Overbey EG; Zoller JA; Mathieu J; Ruohola-Baker H; Ware CB; Hawkins RD
Stem Cell Reports; 2019 May; 12(5):1129-1144. PubMed ID: 31056477
[TBL] [Abstract][Full Text] [Related]
17. Reorganization of enhancer patterns in transition from naive to primed pluripotency.
Buecker C; Srinivasan R; Wu Z; Calo E; Acampora D; Faial T; Simeone A; Tan M; Swigut T; Wysocka J
Cell Stem Cell; 2014 Jun; 14(6):838-53. PubMed ID: 24905168
[TBL] [Abstract][Full Text] [Related]
18. Pluripotency transcription factors and Tet1/2 maintain Brd4-independent stem cell identity.
Finley LWS; Vardhana SA; Carey BW; Alonso-Curbelo D; Koche R; Chen Y; Wen D; King B; Radler MR; Rafii S; Lowe SW; Allis CD; Thompson CB
Nat Cell Biol; 2018 May; 20(5):565-574. PubMed ID: 29662175
[TBL] [Abstract][Full Text] [Related]
19. The chromatin accessibility landscape reveals distinct transcriptional regulation in the induction of human primordial germ cell-like cells from pluripotent stem cells.
Wang X; Veerapandian V; Yang X; Song K; Xu X; Cui M; Yuan W; Huang Y; Xia X; Yao Z; Wan C; Luo F; Song X; Wang X; Zheng Y; Hutchins AP; Jauch R; Liang M; Wang C; Liu Z; Chang G; Zhao XY
Stem Cell Reports; 2021 May; 16(5):1245-1261. PubMed ID: 33930315
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor AP-2γ induces early Cdx2 expression and represses HIPPO signaling to specify the trophectoderm lineage.
Cao Z; Carey TS; Ganguly A; Wilson CA; Paul S; Knott JG
Development; 2015 May; 142(9):1606-15. PubMed ID: 25858457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
